Tip: Access positions for across all investors

Analyze quarterly positions in Rani Therapeutics Hldgs with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Rani Therapeutics Hldgs stock

Who bought or sold RANI THERAPEUTICS HLDGS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of
Nan Fung Group Holdings 494k $6.7M 0% Mar 2022
United Services Automobile Association 481k $6.5M 100% Mar 2022
Vanguard Group 290k $3.9M 100% Mar 2022
Alpha Square Group S 102k $1.4M 0% Mar 2022
Aspireon Wealth Advisors 72k $742k 100% Jun 2022
Geode Capital Management 71k $962k 13% Mar 2022
Marc Lasry 63k $848k 100% Mar 2022
Stifel Financial 42k $566k 5% Mar 2022
Millennium Management 33k $439k 100% Mar 2022
Goldman Sachs Group 27k $362k 100% Mar 2022
State Street Corporation 26k $353k 33% Mar 2022

Setup an alert

Want to be notified whenever an investor makes a significant change to their holdings of Rani Therapeutics Hldgs?

Advisor Group Holdings 19k $261k -8% Mar 2022
Crossvault Capital Management 14k $148k 100% Jun 2022
Wells Fargo & Company 13k $168k 1247200% Mar 2022
Northern Trust 11k $154k 0% Mar 2022
Islay Capital Management 9.6k $99k 100% Jun 2022
Canton Hathaway 8.6k $89k 100% Jun 2022
UBS Group 3.6k $50k -31% Mar 2022
Morgan Stanley 3.3k $44k 100% Mar 2022
Jpmorgan Chase & Co 2.3k $31k -44% Mar 2022
Tower Research Capital 538.00 $7.0k -80% Mar 2022
Pnc Financial Services 300.00 $4.0k 0% Mar 2022
Daiwa Securities Group 58.00 $1.0k 0% Mar 2022

Who sold out of Rani Therapeutics Hldgs?

Fund or Company Name Date Sold Shares Held Valued At
Squarepoint Ops Dec 2021 50k $818k
Caas Capital Management Dec 2021 14k $228k
Bank of America Corporation Dec 2021 4.4k $73k
Signature Dec 2021 65.00 $999.999000